Tagraxofusp Achieves Anti-Tumor Activity with Rapid Restoration of Normal Hematopoiesis in Treatment-Naïve Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Subanalysis of a Pivotal Trial
Year: 2024
Type: conference-abstract
Source: Blood
Institutions: Albert Einstein College of Medicine, The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center, City Of Hope National Medical Center, Novant Health, Roswell Park Comprehensive Cancer Center, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbia University Irving Medical Center, Herbert Irving Comprehensive Cancer Center, Dana-Farber Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405040317